key: cord-0854921-7koxfybo authors: Renaud‐Picard, Benjamin; Gallais, Floriane; Riou, Marianne; Chatron, Eva; Degot, Tristan; Freudenberger, Sophie; Porzio, Michele; Schuller, Armelle; Stauder, Julien; Hirschi, Sandrine; Kessler, Romain title: The social and clinical impact of the COVID‐19 epidemic on the Strasbourg lung transplant cohort: A single‐center retrospective cohort study date: 2020-10-26 journal: Clin Transplant DOI: 10.1111/ctr.14119 sha: 4c8fb6d14b1a4854e006f2bd547f1ef6de8308cd doc_id: 854921 cord_uid: 7koxfybo The clinical and social impacts of the COVID‐19 epidemic on lung transplant (LTx) recipients remain poorly known. We aimed to evaluate its social, clinical, and behavioral consequences on the LTx patients followed in Strasbourg university hospital. A questionnaire was used to collect details concerning patients’ lifestyles, their protection methods used to avoid COVID‐19 contamination, and clinical infection‐related information for March 2020. A specific score was created to quantify patients’ contacts and the associated risk of infectious contagion. Data were collected from 322 patients (91.2%). A majority reported a higher application than usual of social distancing and barrier measures. 43.8% described infectious‐related symptoms and 15.8% needed an anti‐infective treatment. There was no difference in symptom onset according to age, native lung disease, diabetes, or obesity. Nineteen patients were tested for COVID‐19, and four were diagnosed positive, all with a favorable outcome. The infection risk contact score was higher for symptomatic patients (p: 0.007), those needing extra‐medical appointments (p < .001), and those receiving anti‐infective treatments (p = .02). LTx patients reported a careful lifestyle and did not seem at higher risk for COVID‐19. Our score showed encouraging preliminary results and could become a useful tool for the usual infection‐related follow‐up of the LTx patients. population. 6 It is also interesting to consider that SOT recipients' lifestyles are often different to those of the general population with a greater respect of self-protective measures, even when there is not an epidemic. The "Grand Est" region of France was one of the most affected by the COVID-19 epidemic. Strasbourg University Hospital has one of the largest French cohorts of LTx patients, with a follow-up for more than 350 patients. With this study, we wanted to understand the social and clinical impact of the COVID-19 epidemic on the Strasbourg LTx cohort, as well as whether these patients' lifestyles and characteristics had an influence. We hypothesized that LTx patients from our cohort were not at higher risk of being infected by COVID-19 or of developing more severe forms of the infection compared to the rest of the population, partly because of their behavior with regard to the risk of infection. The first aim of this study was to describe the lifestyles of the LTx patients followed at Strasbourg University Hospital, as well as the protective measures they applied during the COVID-19 epidemic. To this end, we used a composite criterion to assess the proportion of patients that (1) complied with home confinement and social distancing, (2) continued to go outside their home, (3) used protective masks, (4) purchased basic necessities (groceries and medication) themselves, and (5) continued their professional activities. The study's secondary objectives were (1) to assess the patients' contacts with their friends and family using a specific score developed in our department, (2) to determine whether the patients' native lung disease, age, sex, or smoking status impacted their compliance with protective measures, and (3) to assess the clinical impact of the COVID-19 epidemic on this cohort (acute symptom onset, unscheduled medical appointments needed, and number of patients screened and treated for COVID-19). The study recruited all LTx patients transplanted before March 2020 that were older than 18 years and followed at Strasbourg University Hospital. This study was approved by the Institutional Review Board of the French Learned Society for Respiratory Medicine (CEPRO 2020-025). This was a retrospective, observational, single-center study. To achieve our aims, we used a specific questionnaire developed by staff members from the respiratory department, in order to standardize long-distance follow-up (Appendix). Usual in-hospital follow-up appointments were canceled for the patients considered as stable, due to the epidemic risk. During April 2020, this questionnaire was distributed to LTx patients followed at Strasbourg University Hospital. The information received pertained to the month of March 2020, since a period of lockdown was implemented in France thereafter due to the COVID-19 epidemic and where French government recommended to limit every non-essential activity outside the home, to respect social distancing, and encouraged teleworking. In Strasbourg, LTx patients are trained to frequently wash their hands, respect protective measures such as wearing a protection mask when going to the hospital, respecting social distancing, paying attention to unusual symptoms, and contacting their regular LTx medical manager if necessary, even during "non-pandemic" times. In addition to the official French recommendations, a letter was sent to the LTx patients with specific guidance and advises provided by our department such as avoiding public spaces and contagious people, avoiding non-necessary travels, requesting a work stoppage if impossible to work from home, and trying to live in a different place if presence of COVID-19-like symptoms in one of the family members. Wearing a protection mask when going outside was not requested except when going to the hospital. The questionnaire was directly administered to the patient by a staff member during the follow-up appointment in the clinic, if it was maintained. In case of cancelation, the patient was contacted by phone and the questionnaire was then either submitted by phone, sent by mail or e-mail according to the patient's preference. We were able to collect the following data: • Details about the patient's lifestyle (marital status, number of people living at home, number of children, type of home, professional status). • Symptom onset that was suggestive of an infection. • Any unscheduled medical appointments that were needed and led to the prescription of antibiotic and/or antiviral treatment. • Whether a specific screening test for COVID-19 was performed. • Whether one or more members of the patient's family and friends experienced symptom onset that was suggestive of COVID-19, including whether this required specific medical care and whether it was responsible for changes in the patient's lifestyle. • Compliance with measures required to protect against COVID-19 (self-isolation at home, social distancing, use of personal protective equipment, frequency of hand washing). • Continuation of out-of-home activities (grocery shopping, ongoing professional activities). • Details of all contacts between the patient and their family, friends, others… In order to quantify the patient's social contact during the lockdown period and to estimate the potential induced risk of contagion, we established a specific score based on several criteria that we collected in our questionnaire (Table 1) and on findings from previous studies. 7, 8 We assessed the type of contact (family living at home, friends, shop owners, coworkers, healthcare workers, etc), whether contact occurred once or several times during March 2020, the frequency of contact, and its duration. The attributed risk for every criterion was graded as low, middle-low, middle-high, or high. 8 For repetitive contacts, induced risk was considered as "not important" for non-medical contacts, such as with family members, friends, or shop owners, while "important" related to contacts with healthcare workers or anyone diagnosed with COVID-19. Based on the questionnaire, we graded all the patient's contacts with another person during March, with a score between 8 and 26, based on our grading system and regarding its potential degree of severity. The sum of all the scores was calculated for each patient to determine a total contact-related risk score. The COVID-19 diagnosis was performed with a nasopharyngeal swab using a specific reverse transcription-polymerase chain reaction for SARS-CoV-2 and/or a positive chest CT scan. Patients' data were collected from the computerized medical records (using DxCare software) and laboratory results server. We recorded each patient's gender, age, native lung disease, type of LTx, time post-LTx, detailed maintenance IS treatment, and long-term azithromycin treatment. Among the data we collected, we were also interested in the presence of risk factors for severe COVID-19 infection (smoking status, 9 obesity, 10 hypertension, 11 Continuous variables are presented as mean ± standard deviation (SD) or median with interquartile range, depending on the normality of distribution. The Kolmogorov-Smirnov test was used for normality analysis. Categorical variables are presented as numbers and percentages. Comparison of proportions was made using the chisquared test. The Mann-Whitney U test was applied for the statistical evaluation of differences between two groups. Statistical significance was defined as a two-tailed p value less than or equal to 0.05. All analyses were conducted using SPSS statistical software (version 11). In total, 353 patients are followed up for their lung transplantation as part of the Strasbourg Lung Transplant Program. We contacted 348 of these patients to request they complete our questionnaire (four were hospitalized and thus not able to answer, one was unable to answer for another reason). We were able to obtain information from 322 patients (24 did not answer and two declined to participate in our study) ( Figure 1 ). The questionnaire was directly admin- Note: Clinical score aimed at quantifying patients' social contacts during the COVID-19 lockdown period and at determining the associated potential risk of contagion. The criteria assessed were the type of contacts, whether they happened only once or several times, their frequency, and their duration. Based on the questionnaire, we graded all the contacts that the patient had in March 2020. For repetitive contacts, "low risk" concerned non-medical contacts, such as with family members, friends, or shop owners, while "high risk" related to contacts with healthcare workers or anyone diagnosed with COVID-19. Every contact was scored between 8 and 26, based on our grading system. The sum of all the scores was calculated for each patient to determine a total score. patients, submitted by phone to 83 (25.8%), sent by e-mail to 153 (47.5%), and by mail to 19 (5.9%) of them. The main patient characteristics are summarized in Table 2 . Patients' native lung diseases were divided into four different groups: Group 1 patients were transplanted for chronic obstructive pulmonary disease (COPD) and alpha-1 antitrypsin deficiency (A1ATD), Group 2 for interstitial lung disease, Group We sought to assess the impact of the COVID-19 epidemic on these patients, particularly with regard to the medical care they received and their lifestyle. Patients were asked to report any acute infectious symptoms that could be consistent with COVID-19 that occurred during March 2020. Less than half of patients described symptoms that occurred during this period (43.8%). The most common symptoms reported were rhinorrhea (18.9%), diarrhea (14%), headache (11.8%), fatigue (11.5%), and nasal obstruction (10.2%). Details of other symptoms are presented in Table 3 . The proportion of symptomatic patients was significantly higher in women (p = .02). There was a trend toward a higher presence of symptoms in patients diagnosed with OSA (p = .08). Interestingly, no significant difference was observed regarding patients' age, native lung disease, (Table 3) . We were also interested in the measures adopted by our patients to protect themselves against COVID-19 during the containment period ( Only four patients reported having no contact with their family and friends during the containment period (1.2%). For each patient, we tried to assess the quantity of social contacts with family and friends, as well as the potential infection-related risk of contamination, as described above (Table 1 ). The median contact score was 44 (IQR, 32-57.5) ( Hospital is in charge of one of the largest French cohorts of LTx patients. Due to the high risk associated with COVID-19, our department has had to adapt its activity, including canceling follow-up consultations with many patients, and using telemedicine instead. One of the strengths of this study is that we collected a large amount of data from almost all our patients, rather than just from COVID-19-diagnosed patients. We used the same questionnaire to collect medical and social information from all our patients, allowing us to perform similar and systematic follow-ups for all of them. The COVID-19 outbreak encouraged a significant proportion of our patients to limit their out-of-home activities, more than usual. Indeed, one-third of patients preferred to adhere to strict self-confinement at home. In a recent monocentric study, Bennett et al 19 evaluated the incidence of COVID-19 in 41 LTx patients using a patient-perspective survey. Compared to our results, the authors found a higher proportion of patients with an increased use of face mask (65.8% vs 50.9%), but the proportion of patients reporting an increased handwash and an increased isolation at home were higher in our study (respectively, 81.4% vs 70.7% and 34.2% vs 21.9%). While 43.8% of our patients reported symptoms compatible with COVID-19, there were only 14.5% in the Italian study. We must consider that the number of symptoms screened was more important in our questionnaire. Only one of their patients (2.5%) was diagnosed with COVID-19. Another aim of this study was to assess the social contacts between patients and their family and friends during the containment period. The nature and type of contact varied greatly from patient to patient, which complicated collection of this information. For this reason, we created a score to quantify these contacts and the associated risk of infectious contagion. The results we obtained with this score were encouraging with a significantly higher score in atrisk patients, who subsequently developed symptoms and needed additional medical care. We must acknowledge a lack of specificity for COVID-19 with our score, which could also be used for another We want to confirm our results by prospectively using an updated version of the questionnaire over the next few months, after the end of the lockdown period in France. This would occur in conjunction with the collection of blood samples that would be subject to specific serology for SARS-CoV-2. We aim to investigate a correlation between COVID-19 serologic status and the clinical characteristics of our patients, their lifestyles, and the protective methods they used against COVID-19. In conclusion, we found a high proportion of LTx recipients applying recommended protective measures against the risk of COVID-19 contagion. LTx patients from our cohort did not appear to be more at risk of developing a severe form of the disease, compared to the rest of the population. These patients' usual cautious lifestyles may have played a major role in protection against contagion. In this preliminary study, the results obtained with our infection risk grading score for patients' contacts were encouraging. Given the current epidemic context and the risk of new major infections emerging, further studies are needed to develop more clinical follow-up scores and tools for at-risk populations, such as SOT patients. The authors would like to thank all the persons who contributed to the realization of this study. None of the authors has a financial relationship with a commercial entity that has an interest in the subject of the presented manuscript or other conflicts of interest to disclose. Data available on request from the authors. Benjamin Renaud-Picard https://orcid. org/0000-0003-3492-9486 Eva Chatron https://orcid.org/0000-0002-8210-1272 Case report of COVID-19 in a kidney transplant recipient: Does immunosuppression alter the clinical presentation? First case of COVID-19 in a kidney transplant recipient treated with belatacept COVID-19 in a lung transplant recipient SARS-CoV-2 infection in two patients following recent lung transplantation COVID-19 pneumonia in lung transplant recipients: report of 2 cases Community acquired respiratory and gastrointestinal viral infections: challenges in the immunocompromised host Psychological and behavioral responses in South Korea during the early stages of coronavirus disease 2019 First known person-to-person transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the USA Prevalence, severity and mortality associated with COPD and smoking in patients with COVID-19: A rapid systematic review and meta-analysis High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) Requiring invasive mechanical ventilation. Obesity (Silver Spring) Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Potential influences of obstructive sleep apnea and obesity on COVID-19 severity Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection COVID-19 and stroke-A global World Stroke Organization perspective COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options COVID-19 and liver dysfunction: Current insights and emergent therapeutic strategies Cancer patients in SARS-CoV-2 infection: A nationwide analysis in China Incidence and clinical course of COVID-19 in patients with connective tissue diseases: a descriptive observational analysis Impact of SARS-CoV-2 outbreak on heart and lung transplant: A patient-perspective survey Early Impact of COVID-19 on Solid Organ Transplantation in the United States